Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 79

1.

Systematic review: Renin-angiotensin system inhibitors in chemoprevention of hepatocellular carcinoma.

Barone M, Viggiani MT, Losurdo G, Principi M, Leo AD.

World J Gastroenterol. 2019 May 28;25(20):2524-2538. doi: 10.3748/wjg.v25.i20.2524.

2.

Use of biosimilars in inflammatory bowel disease: a position update of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD).

Fiorino G, Caprioli F, Daperno M, Mocciaro F, Principi M, Viscido A, Fantini MC, Orlando A, Papi C, Annese V, Danese S, Vecchi M, Rizzello F, Armuzzi A; National patients’ association representatives; IG-IBD members.

Dig Liver Dis. 2019 May;51(5):632-639. doi: 10.1016/j.dld.2019.02.004. Epub 2019 Feb 19.

PMID:
30872085
3.

The Spectrum of Small Intestinal Lesions in Patients with Unexplained Iron Deficiency Anemia Detected by Video Capsule Endoscopy.

Contaldo A, Losurdo G, Albano F, Iannone A, Barone M, Ierardi E, Di Leo A, Principi M.

Medicina (Kaunas). 2019 Feb 27;55(3). pii: E59. doi: 10.3390/medicina55030059.

4.

Predictivity of Autoimmune Stigmata for Gluten Sensitivity in Subjects with Microscopic Enteritis: A Retrospective Study.

Losurdo G, Principi M, Iannone A, Giangaspero A, Piscitelli D, Ierardi E, Di Leo A, Barone M.

Nutrients. 2018 Dec 18;10(12). pii: E2001. doi: 10.3390/nu10122001.

5.

Red flags for appropriate referral to the gastroenterologist and the rheumatologist of patients with inflammatory bowel disease and spondyloarthritis.

Felice C, Leccese P, Scudeller L, Lubrano E, Cantini F, Castiglione F, Gionchetti P, Orlando A, Salvarani C, Scarpa R, Vecchi M, Olivieri I, Armuzzi A; Italian SpA-IBD Expert Panel Group.

Clin Exp Immunol. 2019 Apr;196(1):123-138. doi: 10.1111/cei.13246. Epub 2019 Jan 9.

PMID:
30554407
6.

Clinical relevance of serum non-organ-specific antibodies in patients with HCV infection receiving direct-acting antiviral therapy.

Shahini E, Iannone A, Romagno D, Armandi A, Carparelli S, Principi M, Viggiani MT, Ierardi E, Di Leo A, Barone M.

Aliment Pharmacol Ther. 2018 Nov;48(10):1138-1145. doi: 10.1111/apt.14999.

PMID:
30375693
7.

Mesalazine for People with Diverticular Disease: A Systematic Review of Randomized Controlled Trials.

Iannone A, Ruospo M, Wong G, Barone M, Principi M, Di Leo A, Strippoli GFM.

Can J Gastroenterol Hepatol. 2018 Sep 16;2018:5437135. doi: 10.1155/2018/5437135. eCollection 2018.

8.

The PROSIT Cohort of Infliximab Biosimilar in IBD: A Prolonged Follow-up on the Effectiveness and Safety Across Italy.

Armuzzi A, Fiorino G, Variola A, Manetti N, Fries W, Orlando A, Maconi G, Bossa F, Cappello M, Biancone L, Cantoro L, Costa F, D'IncĂ  R, Lionetti P, Principi M, Castiglione F, Annunziata ML, Di Sabatino A, Di Girolamo M, Terpin MM, Cortelezzi CC, Saibeni S, Amato A, Ardizzone S, Guidi L, Danese S, Massella A, Ventra A, Rizzuto G, Massari A, Perri F, Annese V; PROSIT Investigators.

Inflamm Bowel Dis. 2019 Feb 21;25(3):568-579. doi: 10.1093/ibd/izy264.

PMID:
30137352
9.

Chemoprevention of inflammation-related colorectal cancer by silymarin-, acetyl-11-keto-beta-boswellic acid-, curcumin- and maltodextrin-enriched dietetic formulation in animal model.

Girardi B, Principi M, Pricci M, Giorgio F, Iannone A, Losurdo G, Ierardi E, Di Leo A, Barone M.

Carcinogenesis. 2018 Oct 8;39(10):1274-1282. doi: 10.1093/carcin/bgy104.

PMID:
30084990
10.

New fecal test for non-invasive Helicobacter pylori detection: A diagnostic accuracy study.

Iannone A, Giorgio F, Russo F, Riezzo G, Girardi B, Pricci M, Palmer SC, Barone M, Principi M, Strippoli GF, Di Leo A, Ierardi E.

World J Gastroenterol. 2018 Jul 21;24(27):3021-3029. doi: 10.3748/wjg.v24.i27.3021.

11.

A Case of Severe Transaminase Elevation Following a Single Ustekinumab Dose with Remission After Drug Withdrawal.

Lovero R, Losurdo G, Mastromauro M, Castellaneta NM, Mongelli A, Gentile A, Di Leo A, Principi M.

Curr Drug Saf. 2018;13(3):221-223. doi: 10.2174/1574886313666180719165212.

PMID:
30027852
12.

Biological markers for non-celiac gluten sensitivity: a question awaiting for a convincing answer.

Ierardi E, Losurdo G, Piscitelli D, Giorgio F, Amoruso A, Iannone A, Principi M, Di Leo A.

Gastroenterol Hepatol Bed Bench. 2018 Summer;11(3):203-208. Review.

13.

Differences in dietary habits between patients with inflammatory bowel disease in clinical remission and a healthy population.

Principi M, Losurdo G, Iannone A, Contaldo A, Deflorio V, Ranaldo N, Pisani A, Ierardi E, Di Leo A, Barone M.

Ann Gastroenterol. 2018 Jul-Aug;31(4):469-473. doi: 10.20524/aog.2018.0273. Epub 2018 May 7.

14.

Nonalcoholic Fatty Liver Disease in Inflammatory Bowel Disease: Prevalence and Risk Factors.

Principi M, Iannone A, Losurdo G, Mangia M, Shahini E, Albano F, Rizzi SF, La Fortezza RF, Lovero R, Contaldo A, Barone M, Leandro G, Ierardi E, Di Leo A.

Inflamm Bowel Dis. 2018 Jun 8;24(7):1589-1596. doi: 10.1093/ibd/izy051.

PMID:
29688336
15.

Extra-intestinal manifestations of non-celiac gluten sensitivity: An expanding paradigm.

Losurdo G, Principi M, Iannone A, Amoruso A, Ierardi E, Di Leo A, Barone M.

World J Gastroenterol. 2018 Apr 14;24(14):1521-1530. doi: 10.3748/wjg.v24.i14.1521. Review.

16.

Critical flicker frequency test predicts overt hepatic encephalopathy and survival in patients with liver cirrhosis.

Barone M, Shahini E, Iannone A, Viggiani MT, Corvace V, Principi M, Di Leo A.

Dig Liver Dis. 2018 May;50(5):496-500. doi: 10.1016/j.dld.2018.01.133. Epub 2018 Jan 31.

PMID:
29530628
17.

T Helper Lymphocyte and Mast Cell Immunohistochemical Pattern in Nonceliac Gluten Sensitivity.

Losurdo G, Piscitelli D, Pezzuto F, Fortarezza F, Covelli C, Marra A, Iannone A, Amoruso A, Principi M, Ierardi E, Di Leo A.

Gastroenterol Res Pract. 2017;2017:5023680. doi: 10.1155/2017/5023680. Epub 2017 Dec 7.

18.

Probiotic monotherapy and Helicobacter pylori eradication: A systematic review with pooled-data analysis.

Losurdo G, Cubisino R, Barone M, Principi M, Leandro G, Ierardi E, Di Leo A.

World J Gastroenterol. 2018 Jan 7;24(1):139-149. doi: 10.3748/wjg.v24.i1.139. Review.

19.

Tailored therapy guided by multichannel intraluminal impedance pH monitoring for refractory non-erosive reflux disease.

Ranaldo N, Losurdo G, Iannone A, Principi M, Barone M, De Carne M, Ierardi E, Di Leo A.

Cell Death Dis. 2017 Sep 7;8(9):e3040. doi: 10.1038/cddis.2017.436.

20.

Influence of chemotherapy on total energy expenditure in patients with gastrointestinal cancer: A pilot study.

Viggiani MT, Lorusso O, Natalizio F, Principi M, Di Leo A, Barone M.

Nutrition. 2017 Oct;42:7-11. doi: 10.1016/j.nut.2017.05.001. Epub 2017 May 15.

PMID:
28870482

Supplemental Content

Loading ...
Support Center